Showing results (611-620 of 2,485) with videos related to

Sort By:
Pageof 249
The Journal of Antimicrobial Chemotherapy|April 1, 1992
Animal models as predictors of outcome of therapy with broad spectrum cephalosporinsM S Rouse, B M Tallan, N K Henry, et al.
Journal of Medicinal Chemistry|May 26, 1995
Hypoxia-selective antitumor agents. 10. bis(nitroimidazoles) and related Bis(nitroheterocycles): development of derivatives with higher rates of metabolic activation under hypoxia and improved aqueous solubilityM P Hay, H H Lee, W R Wilson, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1990
Ciprofloxacin therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus epidermidisM S Rouse, R M Wilcox, N K Henry, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1984
Synergy of imipenem or penicillin G and aminoglycosides against enterococci isolated from patients with infective endocarditisJ A Indrelie, W R Wilson, J Y Matsumoto, et al.
British Journal of Cancer|February 1, 1984
Selective toxicity of nitracrine to hypoxic mammalian cellsW R Wilson, W A Denny, S J Twigden, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1980
Synergy of penicillin and decreasing concentration of aminoglycosides against enterococci from patients with infective endocarditisJ Y Matsumoto, W R Wilson, A J Wright, et al.
British Journal of Cancer|March 5, 2004
2-Amino metabolites are key mediators of CB 1954 and SN 23862 bystander effects in nitroreductase GDEPTN A Helsby, D M Ferry, A V Patterson, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1994
Failure of time-kill synergy studies using subinhibitory antimicrobial concentrations to predict in vivo antagonism of cephalosporin-rifampin combinations against Staphylococcus aureusC M Brandt, M S Rouse, B M Tallan, et al.
Mayo Clinic Proceedings|January 1, 1978
Cardiobacterium hominis endocarditis. Four cases with clinical and laboratory observationsJ E Geraci, P R Greipp, C J Wilkowske, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1986
Antimicrobial therapy of experimental endocarditis caused by nutritionally variant viridans group streptococciN K Henry, W R Wilson, R B Roberts, et al.
Pageof 249